Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.
Olsen JR, Moughan J, Myerson R, Abitbol A, Doncals DE, Johnson D, Schefter TE, Chen Y, Fisher B, Michalski J, Narayan S, Chang A, Crane CH, Kachnic L. Olsen JR, et al. Among authors: abitbol a. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):400-408. doi: 10.1016/j.ijrobp.2017.02.005. Epub 2017 Feb 13. Int J Radiat Oncol Biol Phys. 2017. PMID: 28463160 Free PMC article.
Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer.
Kachnic LA, Winter KA, Myerson RJ, Goodyear MD, Abitbol AA, Streeter OE, Augspurger ME, Schefter TE, Katz AW, Fisher BJ, Henke LE, Narayan S, Crane CH. Kachnic LA, et al. Among authors: abitbol aa. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):146-157. doi: 10.1016/j.ijrobp.2021.08.008. Epub 2021 Aug 14. Int J Radiat Oncol Biol Phys. 2022. PMID: 34400269 Free PMC article. Clinical Trial.
Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer.
Lewin AA, Derhagopian R, Saigal K, Panoff JE, Abitbol A, Wieczorek DJ, Mishra V, Reis I, Ferrell A, Moreno L, Takita C. Lewin AA, et al. Among authors: abitbol a. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2104-10. doi: 10.1016/j.ijrobp.2011.02.024. Epub 2011 Jun 2. Int J Radiat Oncol Biol Phys. 2012. PMID: 21640490
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
Abitbol A, Abdel-Wahab M, Lewin A, Troner M, Rodrigues MA, Hamilton-Nelson KL, Markoe A. Abitbol A, et al. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):942-7. doi: 10.1016/s0360-3016(02)02816-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12095561 Clinical Trial.
Dose determination in high dose-rate brachytherapy.
Houdek PV, Schwade JG, Wu X, Pisciotta V, Fiedler JA, Serago CF, Markoe AM, Abitbol AA, Lewin AA, Braunschweiger PG, et al. Houdek PV, et al. Among authors: abitbol aa. Int J Radiat Oncol Biol Phys. 1992;24(4):795-801. doi: 10.1016/0360-3016(92)90731-v. Int J Radiat Oncol Biol Phys. 1992. PMID: 1429107
Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol.
Abitbol A, Abdel-Wahab M, Harvey M, Lewin A, Troner M, Hamilton-Nelson K, Wu J, Markoe A. Abitbol A, et al. Am J Clin Oncol. 2005 Oct;28(5):449-55. doi: 10.1097/01.coc.0000164010.12931.cd. Am J Clin Oncol. 2005. PMID: 16199982 Clinical Trial.
Consensus guidelines for high dose rate remote brachytherapy in cervical, endometrial, and endobronchial tumors. Clinical Research Committee, American Endocurietherapy Society.
Nag S, Abitbol AA, Anderson LL, Blasko JC, Flores A, Harrison LB, Hilaris BS, Martinez AA, Mehta MP, Nori D, et al. Nag S, et al. Among authors: abitbol aa. Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1241-4. doi: 10.1016/0360-3016(93)90549-b. Int J Radiat Oncol Biol Phys. 1993. PMID: 8262853
Optimization of high dose-rate cervix brachytherapy; Part I: Dose distribution.
Houdek PV, Schwade JG, Abitbol AA, Pisciotta V, Wu XD, Serago CF, Markoe AM, Lewin AA, Averette HE, Sevin BU, et al. Houdek PV, et al. Among authors: abitbol aa. Int J Radiat Oncol Biol Phys. 1991 Nov;21(6):1621-5. doi: 10.1016/0360-3016(91)90341-z. Int J Radiat Oncol Biol Phys. 1991. PMID: 1938572 Free article.
69 results